Back to Trades
Total Value
$10.9K
Net $10.9K bought
Filing Date
Apr 22, 2026
1 transaction
Purchases
$10.9K
1 transaction
Trade Summary
On Apr 22, 2026, Teleman Dan Benjamin, Chief Executive Officer, Director, purchased $10.9K of Nasus Pharma Ltd (NSRX) across 1 transaction. The filing covers Ordinary Shares and reflects net buying of $10.9K. Reported prices ranged from $3.76. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Nasus Pharma Ltd
- Ticker Symbol
- NSRX
- CIK
- 0002029039
Insider Information
- Role
- Chief Executive Officer, Director
Filing Details
- Filing Date
- Apr 22, 2026
- Transaction Date
- Apr 22, 2026
- Accession Number
- 0001493152-26-018607
- Form Type
- 4
- Net Trading Amount
- $10.9K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 22, 2026 | Ordinary Shares | 2,900 | $3.76 | Purchase | $10.9K |
Want live alerts when Teleman Dan Benjamin trades again?
Download Insider Trades to track NSRX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Consists of: (i) 24,146 ordinary shares, no par value per share ("Ordinary Shares"), and (ii) 132,845 Ordinary Shares issuable upon exercise of outstanding share options that are exercisable within 60 days.